SB 663 Requires health benefit plans to establish equal out of pocket costs for covered oral and intravenously administered chemotherapy medications
Sponsor: Munzlinger
LR Number: 5122S.02C Fiscal Note available
Committee: Small Business, Insurance and Industry
Last Action: 5/16/2014 - S Informal Calendar S Bills for Perfection--SB 663-Munzlinger, with SCS Journal Page:
Title: SCS SB 663 Calendar Position:
Effective Date: Emergency clause

Full Bill Text | All Actions | Amendments/CCRs/CCSs | Available Summaries | Senate Home Page | List of 2014 Senate Bills

Current Bill Summary


SCS/SB 663 - Currently, insurers often require different out of pocket costs for oral and intravenously administered chemotherapy treatments, often requiring higher payments for oral chemotherapy treatments. This act requires insurers that already offer coverage for both treatment options to require the same out of pocket costs for each and forbids the raising of out of pocket costs for intravenously administered treatments to meet the requirement.

This act is similar to SB 308 (2013), SB 577 (2012), and SB 262 (2011).

MICHELA BIRK